跳至主要内容
临床试验/NCT02817334
NCT02817334Unknown2 期

A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery

National Cancer Center, Korea1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
149
试验地点
1
主要终点
detection rate

研究概览

简要总结

Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) has been used for breast cancer surgery such as sentinel lymph node (SLN) mapping and breast cancer localization.

In this study, our hypothesis are as following:

  1. As inject only indocyanine green (ICG), it provide the surgeon visual guidance to ensure better outcome.
  2. indocyanine green (ICG) permitted accurate preoperative and intraoperative detection of the SLNs as well as nonpalpable benign brest lesion in patients with breast cancer.

详细描述

Indocyanine green, ICG (ICG-fluorescence)

  • ICG is the most commonly used fluorophore which approve by FDA.
  • NIR-F imaging with ICG could be used in various surgeries. For example, SLN mapping in breast cancer and localization of liver metastasis, especially superficial lesion
  • Contains sodium iodide, patients who have history of allergy to iodides should be used as caution.

Nonpalpable benign brest lesion localization

  • New method for the localization and resection of non-palpable breast lesions.
  • The breast lesion was correctly localized, and the area of ICG corresponded well to the site of the lesions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • nonpalpable breast tumor < 5cm in patients with breast cancer.
  • consented patients with more than 18 years
  • Eastern Cooperative Oncology Group Performance status 0 or 1
  • patients who need breast biopsy as treatment for breast cancer.

排除标准

  • nonpalpable breast tumor ≥ 5cm in patients with breast cancer.
  • inflammatory cancer of breast or patients who need MRM
  • pregnancy
  • history of severe allergy to ICG(Indocyanine Green)
  • iode hypersensitiveness

研究组 & 干预措施

indocyanine green

Experimental

As inject only indocyanine green (ICG), it provide the surgeon visual guidance to ensure better outcome.

Intervention: Drug: indocyanine green

干预措施: indocyanine green (Drug)

结局指标

主要结局

detection rate

时间窗: one day

after complete resection with intraoperative ultrasound confirmed the lesion

次要结局

  • determine the pathological stability(one day)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

So-Youn Jung

Medical Doctor

National Cancer Center, Korea

研究点 (1)

Loading locations...

相似试验